Oncologists, Oncology Nurses, Oncology Pharmacists
Colorectal Cancer
1. | Summarize emerging safety and efficacy data from pivotal trials of novel targeted therapies used alone or in combination with chemotherapy for the treatment of mCRC (metastatic colorectal cancer) | 2. | Explain the utility of continuing anti-angiogenesis therapy with subsequent lines of therapy post progression |
3. | Identify at least three biomarkers commonly being included in CRC (colorectal cancer) clinical trial analyses |
1. | Summarize emerging safety and efficacy data from pivotal trials of novel targeted therapies used alone or in combination with chemotherapy for the treatment of mCRC (metastatic colorectal cancer) |
2. | Explain the utility of continuing anti-angiogenesis therapy with subsequent lines of therapy post progression |
3. | Identify at least three biomarkers commonly being included in CRC (colorectal cancer) clinical trial analyses |
Supported Browsers: Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8 Google Chrome 28.0+ for Windows, Mac OS, or Linux Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux Safari 5.0+ for Mac OSX 10.5 and above For video playback, install the latest version of Flash or Quicktime. | Supported Phones & Tablets: Android 4.0.3 and above iPhone/iPad with iOS 6.1 or above |